FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to therapy and cardiology, and concerns correction of the endothelial dysfunction. That is ensured by administering an activated potentiated form of antibodies to endothelial nitrogen oxide synthase in a combination with an activated potentiated form of antibodies to a C-terminal fragment of AT1 angiotensin II receptor.
EFFECT: this combined effect provides effective correction of the endothelial function by the synergetic effect of the activated potentiated form of the antibodies.
4 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2542403C2 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2543331C2 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2543332C2 |
| METHOD OF TREATMENT AND PREVENTION OF ARTERIAL HYPERTENSION AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ARTERIAL HYPERTENSION | 2010 |
|
RU2525156C2 |
| METHOD OF TREATING CHRONIC CARDIAC FAILURE AND PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC CARDIAC FAILURE | 2011 |
|
RU2523451C2 |
| METHOD OF TREATING VEGETOVASCULAR DYSTONIA AND PHARMACEUTICAL COMPOSITION FOR TREATING VEGETOVASCULAR DYSTONIA | 2010 |
|
RU2523557C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2541166C2 |
| METHOD FOR INCREASE OF PHARMACOLOGICAL ACTIVITY OF ACTIVE AGENT OF DRUG PREPARATION AND PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2526153C2 |
| METHOD OF TREATING CHRONIC HEART FAILURE AND PHARMACEUTICAL COMPOSITION FOR COMPLEX THERAPY OF CHRONIC HEART FAILURE | 2010 |
|
RU2525155C2 |
| METHOD FOR INCREASING PHARMACOLOGICAL ACTIVITY OF ACTIVE SUBSTANCE OF MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION | 2014 |
|
RU2572706C1 |
